Paediatrics
Driving paediatric clinical research forward and protecting kids through research—not from it
ICON is invested in bringing safe, effective, paediatric-tested treatments to children. We’ve contributed to the approval of 21 paediatric medicinal products.
Clinical research in paediatric populations faces different challenges and requires experienced development experts for study success. Our medical team comprises 36 board-certified paediatricians and physicians who cover the full scope of paediatric clinical development.
Our infrastructure allows us to implement comprehensive development strategies in conjunction with our sponsors. We don’t wait until paediatric programmess are time-critical—we consider paediatrics from the start of adult development programmes, increasing the efficiency of the programme and saving our sponsors time and money.
Paediatric experience over the past five years
We provide support from early engagement all the way to approval.
In the past 5 years, we have participated in 421 Phase I-IV clinical studies involving paediatric patients
-
421
Phase I-IV Clinical studies -
228,477
Paediatric patients -
18,851
Sites
Our global scientific network has extensive experience in paediatric clinical practice and paediatric clinical development. We bring our knowledge, expertise, and passion to deliver successful study strategy and study support at all stages of programme development.
Experience in all facets of paediatric drug development
We leverage a data-driven approach and many years of development experience to provide practical support for paediatric strategic development, study design, feasibility, protocol development, and further paediatric study-related specificities. We provide operational training and support for all paediatric disease conditions, based on a deep knowledge of the global paediatric development landscape.
Our team contains diverse therapeutic specialties and experience, retaining the most experience in clinical development in the following therapeutic areas:
- Neurology
- Musculoskeletal
- Oncology/Haematology/Cell Therapy
- Infectious Diseases
- Respiratory
- Endocrinology
- Gastroenterology
- Allergology
- Cardiology
Successful enrolment starts here
Beyond ICON’s in-house expertise, we have developed individual strategic partnerships with key academic paediatric centres to augment our existing paediatric expertise with insights from research-minded thought leaders. With our Paediatric Research Partners (PRP) located across the world, we have an enhanced ability to design and deliver paediatric clinical trials more effectively and efficiently leading to an ability to offer novel treatment options to children of all ages.
Family-centred clinical development
Clinical research doesn’t just involve the child, it involves the whole family. We lessen the burden of participation for patients and their families, by implementing decentralised clinical trials, in-home clinical services, and other strategies that improve the patient/family experience.
We ensure assents and consents are understandable for children and their parents, engage children in the research conversation, and work closely with patient advocacy groups. We also partner with innovative organisations to ensure our studies are optimised for study success and family engagement.
Our central focus is the safety and best interest of our patients and their families.
For more information, contact us today.
Paediatrics insights
ICON Paediatric experts provide analysis including whitepapers, blogs and contributions to media and industry conversations relating to all aspects of paediatric clinical trials.